# EMPAGLIFLOZIN
> **ANDA212330** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2026-09-22
## Drug
- **FDA Application Number:** ANDA212330
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMPAGLIFLOZIN
- **Generic name:** Empagliflozin
- **Active ingredients:** EMPAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **First approval:** 2026-09-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212330)
---
*MORVS · CC0 1.0*